Integrative review on Acinetobacter baumannii as a multidrug-resistant pathogen: resistance mechanisms and therapeutic perspectives in the context of nosocomial infections
Authors:
- Pedro Henrique Melo LimaPLPedro Henrique Melo Lima
- Caio Ferraz LopesCLCaio Ferraz Lopes
- João Pedro Camargo FreireJFJoão Pedro Camargo Freire
- Lucas Dias FelicianoLFLucas Dias Feliciano
- Rebeca Cristina Oliveira AmorimRARebeca Cristina Oliveira Amorim
- Mateus Lima MotaMMMateus Lima Mota
- Filipe França CirqueiraFCFilipe França Cirqueira
- Fabian Fellipe Bueno LemosFLFabian Fellipe Bueno Lemos
- Silvia Helena Sousa Pietra PedrosoSPSilvia Helena Sousa Pietra Pedroso
- Fabrício Freire de MeloFMFabrício Freire de Melo
Open Access
- 1 January 2025
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e02682025
Abstract
Acinetobacter baumannii is a gram-negative opportunistic pathogen associated with high morbidity and mortality in nosocomial infections, particularly in intensive care units. Multidrug resistance (MDR) is mediated by efflux pumps, lipopolysaccharide modifications, aminoglycoside adenylyltransferases, FosA, structural alterations, and production of enzymes that inactivate antibiotics, such as carbapenemases. These factors limit the therapeutic options and increase clinical challenges, as there are currently few drugs or combinations with therapeutic success against A. baumannii infections. Some strategies and new drugs, such as cefiderocol, eravacycline, sulbactam-darlobactam, tigecycline, and their combinations with colistin, are being tested and have shown apparent advances. This integrative review discusses the current resistance mechanisms and emerging therapeutic strategies aimed at overcoming the growing threat posed by MDR A. baumannii.Keywords
This publication has 135 references indexed in Scilit:
- Ins and Outs of Major Facilitator Superfamily AntiportersAnnual Review of Microbiology, 2008
- High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from KoreaJournal of Antimicrobial Chemotherapy, 2007
- Porins, efflux pumps and multidrug resistance in Acinetobacter baumanniiJournal of Antimicrobial Chemotherapy, 2007
- The worldwide emergence of plasmid-mediated quinolone resistanceThe Lancet Infectious Diseases, 2006
- Reliability of the E-Test Method for Detection of Colistin Resistance in Clinical Isolates of Acinetobacter baumanniiJournal of Clinical Microbiology, 2005
- Mechanism of plasmid-mediated quinolone resistanceProceedings of the National Academy of Sciences, 2002
- Resistance to Trimethoprim-SulfamethoxazoleClinical Infectious Diseases, 2001
- Sulfonamide resistance: mechanisms and trendsDrug Resistance Updates, 2000
- Antibiotic resistance: a current perspectiveBritish Journal of Clinical Pharmacology, 1999
- Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.1993